Skip to content
GLP-1 Thumbnail 2024
White Paper

A New Frontier in Diabetes and Weight Management: The Rise of GLP-1 Receptor Agonists

GLP-1 receptor agonists are transforming how we treat diabetes and weight management. Download this new report to learn more about how this market has evolved and how GlobalData predicts it to grow from here. The report also discusses primary packaging considerations for this new class of medicine, including the sealing solutions available for guaranteeing patient safety and ease of use.

Additional Resources

Here are some other resources you may be interested in.

WHITE PAPER

mRNA: The State of Play in Oncology and Infectious Disease

WHITE PAPER

EU GMP Annex 1 and Parenteral Packaging: A Quality-by-Design Approach to Sterile Manufacturing

WHITE PAPER

Future-proofing Parenteral Packaging Against Nitrosamines